Prof.Calvin C. P. Pang Hong Kong, China

Prof Calvin Chi Pui PANG 彭智培教授 BSc (Lond), DPhil (Oxon), FARVO Current research of Prof Calvin CP Pang in molecular genomics of eye diseases includes glaucoma, vitreoretinal diseases, myopia, uveitis, thyroid eye diseases, retinoblastoma and inherited retina diseases. He also studies pharmacokinetics of green tea catechins, and GHRH receptor antagonists in ocular oxidative stress, inflammation, and degeneration. He advocates the concept of “health care through children eye care” based on his work on children’s eye diseases and childhood myopia. Prof Pang has served as expert reviewer, external examiner and honorary/visiting professor of >60 research funding organizations and high academic institutions worldwide, including the Wellcome Trust, European Research Council, National Eye Institute (USA), National Medical Research Council Singapore, Association of Research in Vision and Ophthalmology (ARVO), National Science Foundation China, Changjiang Scholar Program China, University of Melbourne, Purdue University, National University of Singapore, Aravind Medical Research Foundation (India), and Peking University China. In Prof Pang received the 2016 China State Scientific and Technological Progress Award (SSTPA) second-class, Special Achievement Award of Chinese Ophthalmological Society 2017, Asia-Pacific Academy of Ophthalmology (APAO) Senior Achievement Award 2018 and APAO Outstanding Service in Prevention of Blindness Award 2022. He became an ARVO Fellow in 2018 and was the 2020 ARVO Foundation honoree. He was selected “The Ophthalmologist Power List 2024 and 2025”, top 100 most influential individuals in ophthalmology. Prof Pang has contributed >640 publications in international peer-reviewed journals, number of citations >32,000, h-index: 89, as of October 2025.